Mark J. Casey - 02 Mar 2026 Form 4/A - Amendment Insider Report for NOVAVAX INC (NVAX)

Reporting relationship: EVP, Chief Legal Officer
Issuer ticker: NVAX
Reported as of: 02 Mar 2026
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 09 Mar 2026, 18:09:38 UTC
Original report date: 03 Mar 2026
Prior SEC filing: 03 Mar 2026
Next SEC filing: 05 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Mark J. Casey

Key filing fact

Mark J. Casey filed Form 4/A - Amendment for NOVAVAX INC (NVAX) on 09 Mar 2026.

Key facts

This page summarizes Mark J. Casey's Form 4/A - Amendment filing for NOVAVAX INC (NVAX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 09 Mar 2026, 18:09.

Change

Previous filing in this sequence was filed on 03 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001415297 Primary reporting owner

Casey Mark J

Relationship: EVP, Chief Legal Officer
Address: 21 FIRSTFIELD ROAD, GAITHERSBURG
Signature: /s/ Mark J. Casey
Signature date: 09 Mar 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NVAX transaction Derivative

Non-Statutory Stock Option NQ

Award

Transaction value
Shares: +152,000
Change %
Price: $0.000000^*
Shares after: 152,000
Date: 02 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 152,000
Exercise price: $10.11
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This Form 4/A has been filed solely to amend the exercise price as originally reported in Column 2 and price of derivative security as originally reported in Column 8 of Table II of the Reporting Person's Form 4 filed on March 3, 2026. All other information remains unchanged from the March 3, 2026 filing.

Footnote F2

One quarter (1/4) of the shares subject to this option granted under the Plan vest on the first anniversary of March 2, 2026, and the remaining three-quarters (3/4) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.